Weimin Y. Fan

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Corrigendum to "NEAT1/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder" [Free Radic. Biol. Med. 167 (2021) 1-11].

Corrigendum to "NEAT1/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder" [Free Radic. Biol. Med. 167 (2021) 1-11].

Journal: Free radical biology & medicine
Published: February 14, 2026

Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.

Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.

Journal: Environmental toxicology
Published: September 13, 2022

CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death.

CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death.

Journal: Frontiers in oncology
Published: March 17, 2021

NEAT1/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder.

NEAT1/hsa-miR-372-3p axis participates in rapamycin-induced lipid metabolic disorder.

Journal: Free radical biology & medicine
Published: December 20, 2020

XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.

XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.

Journal: Genomics
Published: October 11, 2020

Branched α-helical peptides enhanced antitumor efficacy and selectivity.

Branched α-helical peptides enhanced antitumor efficacy and selectivity.

Journal: Biomaterials science
Published: October 08, 2020

The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.

The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.

Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: July 31, 2020

hsa_circ_0001955 Enhances In Vitro Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis.

hsa_circ_0001955 Enhances In Vitro Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis.

Journal: Molecular therapy. Nucleic acids
Published: July 26, 2020

RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 Degradation.

RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 Degradation.

Journal: Molecular therapy. Nucleic acids
Published: June 28, 2020

Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.

Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.

Journal: Oncology reports
Published: June 11, 2020

Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.

Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.

Journal: Journal of Cancer
Published: April 28, 2020

MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.

MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.

Journal: Cell death & disease
Published: January 22, 2020
Showing 1-12 of 83

Last Updated: 09/26/2026